Recently released market study: Conjunctivitis - Pipeline Review, H2 2012

Sept. 16, 2012 - PRLog -- Global Markets Direct's, 'Conjunctivitis - Pipeline Review, H2 2012', provides an overview of the Conjunctivitis therapeutic pipeline. This report provides information on the therapeutic development for Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Conjunctivitis. 'Conjunctivitis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/463737_conjunctivitis_pipeline_review_h2_2012.aspx
------------------------------------------------------------

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Conjunctivitis.
* A review of the Conjunctivitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Conjunctivitis pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Conjunctivitis.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Conjunctivitis pipeline depth and focus of Conjunctivitis therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Conjunctivitis Therapeutic Products under Development, Key Players in Conjunctivitis Therapeutics, Conjunctivitis Pipeline Overview, Conjunctivitis Pipeline, Conjunctivitis Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Conjunctivitis Overview
Therapeutics Development
An Overview of Pipeline Products for Conjunctivitis
Conjunctivitis Therapeutics under Development by Companies
Conjunctivitis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Conjunctivitis Therapeutics - Products under Development by Companies
Conjunctivitis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Conjunctivitis Therapeutics Development
Bausch & Lomb Incorporated
Allergan, Inc.
Bayer HealthCare AG
Merck & Co., Inc.
Santen Pharmaceutical Co., Ltd.
ALK-Abello A/S
Sun Pharmaceutical Industries Limited
InSite Vision Incorporated
NanoViricides, Inc.
NovaBay Pharmaceuticals, Inc.
Stallergenes S.A.
Cytos Biotechnology AG
Allergopharma Joachim Ganzer KG
Fovea Pharmaceuticals SA
LABORATOIRES THEA
Oxagen Limited
Foresight Biotherapeutics, Inc.
Redox Pharmaceutical Corporation
Laboratorios LETI S.L.
Morria Biopharmaceuticals Plc
Conjunctivitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Prednisporin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AzaSite Xtra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NVC-422 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Doxovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
OC000459 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CYT003-QbG10 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
rBet v1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mapracorat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EKCCide-I - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KetoNaph - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-7243 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Olea Europaea Pollen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Modified Allergen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grazax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL0704rP - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mutaflor - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALK Ragweed Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Depigoid Birch - Drug Profile
Product Description
Mechanism of Action

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4637...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.